Matches in Nanopublications for { ?s ?p "[Similarly NKX2-5, SPOCK2, SLC16A12, DPYS and GALR2 are candidate biomarkers for colon cancer (methylation range 60%-95%) and GALR2 hypermethylation showed a sensitivity of 85% and specificity of 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP668561.RA7EHBS4YFuamz1qcIRbIAv4Cpnw_968iqvGN6tGrui6A130_assertion description "[Similarly NKX2-5, SPOCK2, SLC16A12, DPYS and GALR2 are candidate biomarkers for colon cancer (methylation range 60%-95%) and GALR2 hypermethylation showed a sensitivity of 85% and specificity of 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668561.RA7EHBS4YFuamz1qcIRbIAv4Cpnw_968iqvGN6tGrui6A130_provenance.
- NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_assertion description "[Similarly NKX2-5, SPOCK2, SLC16A12, DPYS and GALR2 are candidate biomarkers for colon cancer (methylation range 60%-95%) and GALR2 hypermethylation showed a sensitivity of 85% and specificity of 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668562.RA8AATndXE0CyIPPrjZbhZxObnCG_hImynDeDKtew1wzU130_provenance.